Xiaoming Xie

5PUBLICATIONS
29CO-AUTHORS
Tissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 11, 2026
Fasting-Mimicking Diets Reprogram Cancer-Associated Fibroblasts to Reverse the Immunosuppressive Tumor Microenvironment in Breast Cancer.

|Jun 13, 2024
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies.

Jindong Xie, Manqing Liu, Xinpei Deng

|Sep 09, 2022
Effects of Infection-Induced Fever and the Interaction with IL6 rs1800796 Polymorphism on the Prognosis of Breast Cancer.

Hengming Ye, Lu-Ying Tang, Zhuo-Zhi Liang

|May 13, 2022
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.

Yutian Zou, Shaoquan Zheng, Xinhua Xie

|Jun 02, 2018
Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.

Xuan Li, Danian Dai, Bo Chen

Pageof 1

Frequent Collaborators

2 joint publications

Yutian Zou

2 joint publications

Lu Yang

2 joint publications

Zhe-Sheng Chen

2 joint publications

Hailin Tang